PATENT CLAIM ANALYSIS

Application Number: 16090632
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["544", "316000"]

Abstract:
This invention relates to compounds of formula (I), a process for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions having an association with the orexin sub-type 1 receptor. Ar 1  and Ar 2  have meanings given in the description.

Claim (Index 8):
A method of treating a psychiatric or neurological condition associated with impulse control deficits, the method comprising administering a compound according to  claim 1  or a pharmaceutically acceptable salt thereof to a patient in need thereof.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 97.0
- Lexical Diversity: 1.2439
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16090325', '16090332', '14357159', '15308712', '14073907']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7101975693571904
- 35 USC 102 Novelty (BERT): 0.4977493123118314
- Combined Prediction Score: 0.6889527436526545
- Mean Citation Score: 218.10678
- Max Citation Score: 267.7078
- Similarity Product: 228.9338314412117

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test